
[BEGIN TABLE]
 Filed by the Registrant ☒   Filed by a Party other than the Registrant  o  
[END TABLE]
[BEGIN TABLE]
  o   Preliminary Proxy Statement o   Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))  
 ☒   Definitive Proxy Statement o   Definitive Additional Materials o   Soliciting Material Pursuant to § 240.14a-12  
[END TABLE]
[BEGIN TABLE]
 ☒    No fee required.  
  o   Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.  
     (1)   Title of each class of securities to which transaction applies:  
     (2)   Aggregate number of securities to which transaction applies:  
     (3)   Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):  
     (4)   Proposed maximum aggregate value of transaction:  
     (5)   Total fee paid:  
 ☐   Fee paid previously with preliminary materials.  
 ☐   Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.  
     (1)   Amount Previously Paid:  
     (2)   Form, Schedule or Registration Statement No.:  
     (3)   Filing Party:  
     (4)   Date Filed:  
[END TABLE]
[BEGIN TABLE]
     Marilyn Carlson Nelson  
     Chair of the Board  
[END TABLE]
[BEGIN TABLE]
     By Order of the Board of Directors  
     Timothy P. Herbert  
     President, Chief Executive Officer and Secretary  
[END TABLE]
[BEGIN TABLE]
  Page 
GENERAL INFORMATION ABOUT THE ANNUAL MEETING AND VOTING   1   
When and where will the Annual Meeting be held?   1   
What are the purposes of the Annual Meeting?   1   
Are there any matters to be voted on at the Annual Meeting that are not included in this Proxy Statement?   1   
Why did I receive a notice in the mail regarding the Internet availability of proxy materials instead of a paper copy of proxy materials?   1   
What does it mean if I receive more than one Notice and Access Card or more than one set of proxy materials?   2   
Can I vote my shares by filling out and returning the Notice and Access Card?   2   
Who is entitled to vote at the Annual Meeting?   2   
What is the difference between being a "record holder" and holding shares in "street name"?   2   
What do I do if my shares are held in "street name"?   2   
How many shares must be present to hold the Annual Meeting?   2   
What are "broker non-votes"?   3   
What if a quorum is not present at the Annual Meeting?   3   
How do I vote my shares without attending the Annual Meeting?   3   
How can I attend and vote at the Annual Meeting?   3   
What if during the check-in time or during the Annual Meeting I have technical difficulties or trouble accessing the virtual meeting website?   4   
How does the Board recommend that I vote?   4   
How many votes are required to approve each proposal?   4   
What if I do not specify how my shares are to be voted?   4   
Who will count the votes?   4   
Can I revoke or change my vote after I submit my proxy?   5   
Who will pay for the cost of this proxy solicitation?   5   
PROPOSAL NO. 1 ELECTION OF DIRECTORS   6   
Board Size and Structure   6   
Current Directors and Terms   6   
Nominees for Director   6   
Information About Board Nominees and Continuing Directors   6   
Nominees for Election to Three-Year Terms Expiring No Later than the 2022 Annual Meeting   7   
Class II Directors Whose Terms Expire at the 2020 Annual Meeting of Stockholders   8   
Class III Directors Whose Terms Expire at the 2021 Annual Meeting of Stockholders   8   
Board Recommendation   9   
PROPOSAL NO. 2 RATIFICATION OF APPOINTMENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM   10   
Appointment of Independent Registered Public Accounting Firm   10   
Audit, Audit-Related, Tax and All Other Fees   10   
Pre-Approval Policies and Procedures   10   
Board Recommendation   11   
Audit Committee Report   11   
EXECUTIVE OFFICERS   12   
CORPORATE GOVERNANCE   13   
Corporate Governance Guidelines   13   
Board Leadership Structure   13   
Director Independence   14   
Board Committees   14   
[END TABLE]
i
[BEGIN TABLE]
  Page 
Audit Committee   14   
Compensation Committee   15   
Nominating and Corporate Governance Committee   16   
Board and Board Committee Meetings and Attendance   16   
Executive Sessions   16   
Director Attendance at Annual Meeting of Stockholders   16   
Director Nominations Process   16   
Board Role in Risk Oversight   18   
Committee Charters and Corporate Governance Guidelines   18   
Code of Business Conduct and Ethics   18   
Anti-Hedging Policy   18   
Communications with the Board   18   
EXECUTIVE COMPENSATION   19   
Overview   19   
Summary Compensation Table   19   
Narrative to Summary Compensation Table   19   
Outstanding Equity Awards at Fiscal Year-End   24   
DIRECTOR COMPENSATION   25   
IPO Grants to Non-Employee Directors under the 2018 Plan   25   
Non-Employee Director Compensation Policy   25   
STOCK OWNERSHIP   27   
Security Ownership of Certain Beneficial Owners and Management   27   
Section 16(a) Beneficial Ownership Reporting Compliance   29   
CERTAIN TRANSACTIONS WITH RELATED PERSONS   30   
Policies and Procedures on Transactions with Related Persons   30   
Participation in Our Initial Public Offering   30   
Investor Rights Agreement   30   
Voting Agreement   30   
Right of First Refusal and Co-Sale Agreement   31   
Director and Officer Indemnification and Insurance   31   
STOCKHOLDER PROPOSALS AND DIRECTOR NOMINATIONS   32   
HOUSEHOLDING   32   
2018 ANNUAL REPORT   32   
[END TABLE]
ii   
[BEGIN TABLE]
 Proposal   Votes Required   Voting Options   Impact of "Withhold" or "Abstain" Votes   Broker Discretionary Voting Allowed  
 Proposal No. 1:  Election of Directors   The plurality of the votes cast. This means that the two nominees receiving the highest number of affirmative "FOR" votes will be elected as Class I directors.   "FOR ALL" "WITHHOLD ALL" "FOR ALL EXCEPT"   None(1)   No(3)  
 Proposal No. 2:  Ratification of Appointment of Independent Registered Public Accounting Firm   The affirmative vote of the holders of a majority in voting power of the votes cast affirmatively or negatively (excluding abstentions) at the Annual Meeting by the holders entitled to vote thereon.   "FOR" "AGAINST" "ABSTAIN"   None(2)   Yes(4)  
[END TABLE]
 5
[BEGIN TABLE]
 Class I Director – Current Term Ending at 2019 Annual Meeting   Class II Director – Current Term Ending at 2020 Annual Meeting   Class III Director – Current Term Ending at 2021 Annual Meeting  
 Timothy Herbert Chau Khuong Shawn T McCormick   Joyce Erony Mudit K. Jain Dana G. Mead, Jr.   Marilyn Carlson Nelson Jerry Griffin, M.D. Casey Tansey  
[END TABLE]
[BEGIN TABLE]
 Class I Directors   Age   Served as a Director Since   Current Positions  with Inspire  
 Timothy Herbert   56   November 2007   Chief Executive Officer, President and Director  
 Chau Khuong   43   April 2014   Director  
 Shawn T McCormick   54   January 2017   Director  
[END TABLE]
[BEGIN TABLE]
 Class II Directors   Age   Director Since   Current Position  at Inspire  
 Joyce Erony   59   November 2016   Director  
 Mudit K. Jain   50   May 2009   Director  
 Dana G. Mead   59   January 2008   Director  
[END TABLE]
[BEGIN TABLE]
 Class III Directors   Age   Director Since   Current Position  at Inspire  
 Marilyn Carlson Nelson   79   November 2016   Chair of the Board  
 Jerry Griffin, M.D.   74   January 2008   Director  
 Casey Tansey   61   January 2008   Director  
[END TABLE]
 9
[BEGIN TABLE]
  Year Ended December 31, 
  2018 2017 
Audit Fees(1) $ 605,061   $ 76,438   
Audit-Related Fees(2)   0     0   
Tax Fees(3)   55,711     31,658   
All Other Fees(4)   2,000     0   
Total $ 662,772   $ 108,096   
[END TABLE]
 11
[BEGIN TABLE]
 Executive Officer   Age   Position   In Current Position Since  
 Timothy Herbert   56   Chief Executive Officer, President and Director   2007  
 Richard Buchholz   51   Chief Financial Officer   2014  
 Randy Ban   54   Senior Vice President, Global Sales and Marketing   2009  
 Steven Jandrich   52   Chief Compliance Officer and Vice President, Human Resources   2017  
[END TABLE]
 13
[BEGIN TABLE]
 Director   Audit Committee   Compensation Committee   Nominating and Corporate Governance Committee  
 Joyce Erony   —   —   Chair  
 Jerry Griffin, M.D.   —   X   X  
 Timothy Herbert   —   —   —  
 Mudit K. Jain   X   —   —  
 Chau Khuong   —   X   —  
 Dana G. Mead, Jr.   X   —   —  
 Shawn T McCormick   Chair   —   —  
 Marilyn Carlson Nelson   —   —   X  
 Casey Tansey   —   Chair   —  
[END TABLE]
[BEGIN TABLE]
Name and Principal Position Year Salary ($) Option Awards ($)(1) Non-Equity Incentive Plan Compensation ($)(2) Total ($) 
Timothy Herbert President and Chief Executive Officer    2018     417,606     2,424,007     419,156     3,260,769   
  2017     380,000     83,901     135,660     599,561   
Richard Buchholz Chief Financial Officer    2018     311,269     656,960     190,603     1,158,832   
  2017     255,748     8,708     65,216     329,672   
Randy Ban Senior Vice President of Global Sales and Marketing    2018     287,907     538,000     237,444     1,063,351   
  2017     278,168     19,818     215,225     513,211   
[END TABLE]
    23
[BEGIN TABLE]
Name Grant Date Number of Securities Underlying Unexercised  Options (#) Exercisable(2) Number of Securities Underlying Unexercised  Options (#) Unexercisable(2) Option Exercise Price ($)(2) Option Expiration Date 
Timothy P. Herbert   8/15/2009     30,075     —     3.26     8/14/2019   
    5/1/2012     167,067     —     1.47     4/30/2022   
    9/12/2013     134,586     —     1.14     9/11/2023   
    3/31/2014     176,691     —     2.07     3/30/2024   
    1/1/2017     27,740     30,154     0.94     12/31/2026   
    4/1/2017     63,408     88,772     0.94     3/31/2027   
    4/9/2018     —     112,781     10.38     4/8/2028   
    12/18/2018     —     85,000     42.15     12/18/2028   
Richard J. Buchholz   6/1/2014     82,706     —     2.07     5/31/2024   
    1/1/2017     2,881     3,134     0.94     12/31/2026   
    4/1/2017     6,578     9,211     0.94     3/31/2027   
    4/9/2018     —     22,556     10.38     4/8/2019   
    12/18/2018     —     25,000     42.15     12/18/2028   
Randy A. Ban   5/1/2012     46,390     —     1.47     4/30/2022   
    9/12/2013     75,187     —     1.14     9/11/2023   
    3/31/2014     27,067     —     2.07     3/30/2024   
    1/1/2017     6,484     7,049     0.94     12/31/2026   
    4/1/2017     15,037     21,053     0.94     3/31/2027   
    12/18/2018     —     25,000     42.15     12/18/2028   
[END TABLE]
[BEGIN TABLE]
Name Fees Earned or  Paid in Cash ($) Option Awards ($)(2)(3) Total ($) 
Joyce Erony   33,104     110,000     143,104   
Jerry Griffin, M.D.   34,760     110,000     144,760   
Mudit K. Jain   33,032 (1)    110,000     143,032   
Chau Khuong   31,384 (1)    110,000     141,384   
Dana G. Mead, Jr.   33,104     110,000     143,104   
Shawn T McCormick   39,725     110,000     149,725   
Marilyn Carlson Nelson   52,084 (1)    110,000     162,084   
Casey Tansey   36,365 (1)    110,000     146,365   
[END TABLE]
[BEGIN TABLE]
Name Number of Shares of Common Stock Underlying  Options Outstanding at Fiscal Year End 
Joyce Erony   17,296   
Jerry Griffin, M.D.   28,573   
Mudit K. Jain   17,296   
Chau Khuong   17,296   
Dana G. Mead, Jr.   17,296   
Shawn T McCormick   32,333   
Marilyn Carlson Nelson   39,851   
Casey Tansey   17,296   
[END TABLE]
[BEGIN TABLE]
Name of Beneficial Owner Number of Shares Beneficially Owned Percentage of Shares Beneficially Owned 
Holders of More than 5%:              
Synergy Life Science Partners, LP(1)   2,095,507     8.9% 
OrbiMed Private Investments V, L.P.(2)   1,829,449     7.8% 
KPCB Holdings, Inc.(3)   1,756,306     7.5% 
Amzak Health Investors, LLC(4)   1,497,043     6.4% 
U.S. Venture Partners IX, L.P.(5)   1,392,533     5.9% 
Named executive officers and directors:              
Timothy Herbert(6)   879,269     3.6% 
Randy Ban(7)   196,308       * 
Richard Buchholz(8)   96,826       * 
Marilyn Carlson Nelson(9)   672,505     2.9% 
Joyce Erony(10)   704,339     3.0% 
Jerry Griffin, M.D. (11)   83,685       * 
Mudit K. Jain(12)   18,059       * 
Chau Khuong(13)   18,021       * 
Dana G. Mead, Jr.(14)   37,296       * 
Shawn T McCormick(15)   42,851       * 
Casey Tansey(16)   216,899       * 
All executive officers and directors as a group (12 individuals)(17)   2,981,891     12.1% 
[END TABLE]
  29
[BEGIN TABLE]
Participants Shares Purchased Aggregate Purchase Price 
    (in thousands)  
Greater than 5% Stockholders              
Orbimed Private Investments V, L.P.(1)   312,500   $ 5,000   
Amzak Health Investors, LLC(2)   125,000   $ 2,000   
Directors and Affiliates              
GDN Holdings, LLC(3)   62,500   $ 1,000   
Dana G. Mead, Jr.   20,000   $ 320   
Casey Tansey   187,500   $ 3,000   
[END TABLE]
  32
[BEGIN TABLE]
     By Order of the Board of Directors  
     Timothy P. Herbert  
     President, Chief Executive Officer and Secretary  
[END TABLE]
  